Wordt geladen...
Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation
BACKGROUND: High intensity treatments such as hematopoietic cell transplantation (HCT) can be curative for patients with hematologic malignancies, but this needs to be balanced by the high risk of nonrelapse mortality (NRM) during the first 2 years after HCT. Sarcopenia (low muscle mass) is associat...
Bewaard in:
| Gepubliceerd in: | J Natl Cancer Inst |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6695315/ https://ncbi.nlm.nih.gov/pubmed/30951603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy231 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|